A.d.i. (thea) Van Asselt
Post-doc Researcher
Science and Engineering
University of Groningen
Netherlands
Biography
A.D.I. (Thea) van Asselt, post-doc researcher, Other positions: health economist at UMCG, department of Epidemiology, Faculty of Science and Engineering PharmacoTherapy, -Epidemiology and -Economics — Groningen Research Institute of Pharmacy Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands.
Research Interest
Health Economics, Pharmacoeconomics, Economic modelling, Quality of Life, Health Technology Assessment (HTA)
Publications
-
Tomini, F., Prinzen, F., & van Asselt, A. D. I. (2016). A review of economic evaluation models for cardiac resynchronization therapy with implantable cardioverter defibrillators in patients with heart failure. European Journal of Health Economics, 17(9), 1159-1172. DOI: 10.1007/s10198-015-0752-3
-
Zakiyah, N., van Asselt, A. D. I., Roijmans, F., & Postma, M. J. (2016). Economic Evaluation of Family Planning Interventions in Low and Middle Income Countries: A Systematic Review. PLoS ONE, 11(12), [0168447]. DOI: 10.1371/journal.pone.0168447, 10.1371/journal.pone.0168447
-
Broekema, A. E. H., Kuijlen, J. M. A., Lesman-Leegte, G. A. T., Bartels, R. H. M. A., van Asselt, A. D. I., Vroomen, P. C. A. J., ... FACET study group investigators (2017). Study protocol for a randomised controlled multicentre study: the Foraminotomy ACDF Cost-Effectiveness Trial (FACET) in patients with cervical radiculopathy. BMJ Open, 7(1), [e012829]. DOI: 10.1136/bmjopen-2016-012829
-
Ramaekers, B. L. T., Riemsma, R., Tomini, F., van Asselt, T., Deshpande, S., Duffy, S., ... Joore, M. A. (2017). Abiraterone Acetate for the Treatment of Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of an NICE Single Technology Appraisal. Pharmacoeconomics, 35(2), 191-202. DOI: 10.1007/s40273-016-0445-5, 10.1007/s40273-016-0445-5
-
Zakiyah, N., van Asselt, A. D. I., & Postma, M. J. (2017). Ulipristal acetate for pre-operative treatment of moderate-to-severe uterine fibroids in women of reproductive age in The Netherlands: cost minimization analysis and budget impact analysis. Journal of Medical Economics, 20(3), 280-287. DOI: 10.1080/13696998.2016.1254090
